HONG Hao. Advantages and Challenges of Radionuclide Coupled Drugs Development[J]. Progress in Pharmaceutical Sciences, 2023, 47(5): 321-323. DOI: 10.20053/j.issn1001-5094.2023.05.001
Citation:
|
HONG Hao. Advantages and Challenges of Radionuclide Coupled Drugs Development[J]. Progress in Pharmaceutical Sciences, 2023, 47(5): 321-323. DOI: 10.20053/j.issn1001-5094.2023.05.001
|
HONG Hao. Advantages and Challenges of Radionuclide Coupled Drugs Development[J]. Progress in Pharmaceutical Sciences, 2023, 47(5): 321-323. DOI: 10.20053/j.issn1001-5094.2023.05.001
Citation:
|
HONG Hao. Advantages and Challenges of Radionuclide Coupled Drugs Development[J]. Progress in Pharmaceutical Sciences, 2023, 47(5): 321-323. DOI: 10.20053/j.issn1001-5094.2023.05.001
|